Skip to main navigation Skip to search Skip to main content

Primary Extranodal Follicular Lymphoma: A Retrospective Survey of the International Extranodal Lymphoma Study Group (IELSG)

  • Annarita Conconi
  • , Andrea Janikova
  • , Barbara Vannata
  • , Ana Florencia Ramírez‐Ibarguen
  • , Chiara Lobetti‐Bodoni
  • , David Belada
  • , Maria Cristina Pirosa
  • , Michael Mian
  • , Andrés J. M. Ferreri
  • , Gail Ryan
  • , Gerassimos Pangalis
  • , Maria Elena Cabrera
  • , Stefano Luminari
  • , Silvia Montoto
  • , Richard Tsang
  • , Igor Aurer
  • , Carlo Visco
  • , Gloria Margiotta Casaluci
  • , Vit Prochazka
  • , Samuel Hricko
  • Anastasios Stathis, Luca Mazzucchelli, Maurilio Ponzoni, Massimo Federico, Gianluca GAIDANO, Armando Lopez‐Guillermo, Barbara Pro, Davide Rossi, Luciano Cascione, Grzegorz Nowakowsky, Marek Trneny, Emanuele Zucca

Research output: Contribution to journalArticlepeer-review

Abstract

The characteristics at diagnosis and clinical course of primary extranodal follicular lymphoma (EFL) have not been extensively described. The International Extranodal Lymphoma Study Group (IELSG) conducted an international retrospective survey aimed to describe the clinical features at diagnosis and the outcomes of FL cases with a clinically dominant extranodal component. The dataset included 605 pathologically reviewed cases from 19 different countries, and their outcomes were compared to those of nodal follicular lymphomas. The two most common presentation sites for EFL were the skin (n = 334) and the gastrointestinal tract (n = 72), with 22 cases having primary duodenal localization. These subsets exhibited unique features at diagnosis and significantly different overall survival (OS) patterns. After a median follow-up of 5.5 years, primary cutaneous lymphomas showed a superior outcome [10-year OS: 89% (95% CI, 83%–93%)], while primary gastrointestinal lymphomas had an intermediate outcome [10-year OS: 79% (95% CI, 59%–90%)]. Among the gastrointestinal lymphomas, primary duodenal lymphomas tended toward the best outcome [10-year OS: 95% (95% CI, 69%–99%)]. Other primary extranodal sites had inferior outcomes [10-year OS: 59% (95% CI, 48%–68%)], similar to primary nodal lymphomas [10-year OS: 57% (95% CI, 49%–64%)]. These findings support the identification of specific primary FL localizations as distinct entities with particular clinical and biological characteristics.
Original languageEnglish
JournalHematological Oncology
Volume43
Issue number4
DOIs
Publication statusPublished - 2025

Keywords

  • FLIPI
  • cutaneous follicular lymphoma
  • duodenal follicular lymphoma
  • extranodal follicular lymphoma
  • follicular lymphoma international prognostic Index
  • gastrointestinal follicular lymphoma

Fingerprint

Dive into the research topics of 'Primary Extranodal Follicular Lymphoma: A Retrospective Survey of the International Extranodal Lymphoma Study Group (IELSG)'. Together they form a unique fingerprint.

Cite this